Proteomic analysis of the nuclear matrix in the early stages of rat liver carcinogenesis: Identification of differentially expressed and MAR-binding proteins

Experimental Cell Research

Volumn 315, Issue 2, 2009, Pages 226-239

  Barboro, Paola ^a   D'Arrigo, Cristina ^b   Repaci, Erica ^a   Bagnasco, Luca ^a,c   Orecchia, Paola ^a   Carnemolla, Barbara ^a   Patrone, Eligio ^b   Balbi, Cecilia ^a  

^a UNIVERSITY OF GENOA   (Italy)

^b CNR   (Italy)

^c UNIVERSITY OF GENOA   (Italy)

Author keywords

Hepatocytes; Heterogeneous nuclear ribonuclearproteins; Lamins; Matrix Attachment Regions; Nuclear Matrix; Nuclear mitotic apparatus protein; Persistent hepatocyte nodules; Proteomics

Indexed keywords

LAMIN; MATRIX ATTACHMENT REGION BINDING PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL NUCLEUS MATRIX; CELL STRUCTURE; CHROMATIN ASSEMBLY AND DISASSEMBLY; CONTROLLED STUDY; LIVER CARCINOGENESIS; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN INTERACTION; PROTEIN MODIFICATION; PROTEOMICS; RAT;

RATTUS;

EID: 57749204774     PISSN: 00144827     EISSN: 10902422     Source Type: Journal    
DOI: 10.1016/j.yexcr.2008.10.017     Document Type: Article

References (53)

1. Zaidi S.K., Young D.W., Javed A., Pratap J., Montecino M., van Wijnen A., Lian J.B., Stein J.L., and Stein G.S. Nuclear microenvironments in biological control and cancer. Nat. Rev. Cancer 7 (2007) 454-463
2. Ducasse M., and Brown M.A. Epigenetic aberrations and cancer. Mol. Cancer 5 (2006) 60
3. Zink D., Fisher A.H., and Nickerson J.A. Nuclear structure in cancer cells. Nat. Rev. Cancer 4 (2004) 677-687
4. Berezney R., Basler J., Hughes B.B., and Kaplan S.C. Isolation and characterization of the nuclear matrix from Zajdela ascites hepatoma cells. Cancer Res. 39 (1979) 3031-3039
5. Partin A., Getzenberg R., Carmichael M., Vindivich D., Yoo J., Epstein J., and Coffey D. Nuclear matrix protein patterns in human benign prostatic hyperplasia and prostate cancer. Cancer Res. 53 (1993) 744-746
6. Getzenberg R., Konety B., Oeler T., Quigley M., Hakam A., Becich M., and Bahnson R. Bladder cancer-associated nuclear matrix proteins. Cancer Res. 56 (1996) 1690-1694
7. Koney B., Nangia A., Nguyen T., Veitmeier B., Dhir R., Acierno J., Becich M., Hrebinko R., and Getzenberg R. Identification of nuclear matrix protein alterations associated with renal cell carcinoma. J. Urol. 159 (1998) 1359-1363
8. Brunagel G., Veitmeier B., Bauer A., Schoen R., and Getzenberg R. Identification of nuclear matrix protein alterations associated with human colon cancer. Cancer Res. 62 (2002) 2437-2442
9. Brunagel G., Schoen R.E., Bauer A.J., Vietmeier B.N., and Getzenberg R.H. Nuclear matrix protein alterations associated with colon cancer metastasis to the liver. Clin. Cancer Res. 8 (2002) 3039-3045
10. Lakshmanan Y., Subong E.N.P., and Partin A.W. Differential nuclear matrix protein expression in prostate cancer: correlation with pathologic stage. J. Urol. 159 (1998) 1354-1358
11. Barboro P., Pasini A., Parodi S., Balbi C., Cavazza B., Allera C., Lazzarini G., and Patrone E. Chromatin changes in cell transformation: progressive unfolding of the higher-order structure during the evolution of rat hepatocyte nodules. A differential scanning calorimetry study. Biophys. J. 65 (1993) 1690-1699
12. Barboro P., Alberti I., Sanna P., Parodi S., Balbi C., Allera C., and Patrone E. Changes in the cytoskeletal and nuclear matrix proteins in rat hepatocyte neoplastic nodules in their relation to the process of transformation. Exp. Cell Res. 225 (1996) 315-327
13. Chattopadhyay S., and Pavithra L. MARs and MARBPs: key modulators of gene regulation and disease manifestation. In: Kundu T.K., and Dasgupta D. (Eds). Chromatin and Disease (2007), Springer 213-230
14. Hozàk P., Sasseville A.M., Raymond Y., and Cook P.R. Lamin proteins form an internal nucleoskeleton as well as a peripheral lamina in human cells. J. Cell Sci. 108 (1995) 635-644
15. Neri L.M., Raymond Y., Giordano A., Capitani S., and Martelli A.M. Lamin A is part of the internal nucleoskeleton of human erythroleukemia cells. J. Cell Physiol. 178 (1999) 284-295
16. Zeng C., He D., and Brinkley B.R. Localization of NuMA protein isoforms in the nuclear matrix of mammalian cells. Cell Motil. Cytoskelet. 29 (1994) 167-176
17. Barboro P., D'Arrigo C., Diaspro A., Mormino M., Alberti I., Parodi S., Patrone E., and Balbi C. Unraveling the organization of the internal nuclear matrix: RNA-dependent anchoring of NuMA to a lamin scaffold. Exp. Cell Res. 279 (2002) 202-218
18. Barboro P., D'Arrigo C., Mormino M., Coradeghini R., Parodi S., Patrone E., and Balbi C. An intranuclear frame for chromatin compartimentalization and high-order folding. J. Cell. Biochem. 88 (2003) 113-120
19. Semple-Roberts E., Hayes M.A., Armstrong D., Becker R.A., Racz W.J., and Farber E. Alternative methods of selecting rat hepatocellular nodules resistant to 2-acetylaminofluorene. Int. J. Cancer 15 (1987) 643-645
20. Farber E., and Sarma D.S.R. Chemical carcinogenesis: the liver is a model. In: Maskens A.R., Ebbesen R., and Burny A. (Eds). Concepts and Theories in Carcinogenesis (1987), Elsevier, Amsterdam 185-220
21. Barboro P., Rubagotti A., Orecchia P., Spina B., Truini M., Repaci E., Carmignani G., Romagnoli A., Introini C., Boccardo F., Carnemolla B., and Balbi C. Differential proteomic analysis of nuclear matrix in muscle-invasive bladder cancer: potential to improve diagnosis and prognosis. Cell. Oncol. 30 (2008) 13-26
22. Heukeshoven J., and Dernick R. Improved silver staining procedure for fast staining in PhastSystem Development unit I. Staining of sodium dodecyl sulfate gels. Electrophoresis 9 (1988) 28-32
23. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227 (1970) 680-685
24. Hakes D.J., and Berezney R. DNA binding properties of the nuclear matrix and individual nuclear matrix proteins. J. Biol. Chem. 266 (1991) 11131-11140
25. Alberti I., Barboro P., Barbesino M., Sanna P., Pisciotta L., Parodi S., Nicolò G., Boccardo F., Galli S., Patrone E., and Balbi C. Changes in the expression of cytokeratins and nuclear matrix proteins are correlated with the level of differentiation in human prostate cancer. J. Cell. Biochem. 79 (2000) 471-485
26. Candiano G., Bruschi M., Musante L., Santucci L., Ghiggeri G.M., Carnemolla B., Orecchia P., Zardi L., and Rigetti P.G. Blue Silver: a very sensitive colloidal Coomassie G-250 staining for proteome analysis. Electrophoresis 25 (2004) 1327-1333
27. Bottino C., Castriconi R., Pende D., Rivera P., Nanni M., Carnemolla B., Cantoni C., Grassi J., Marcenaro S., Reymond N., Vitale M., Moretta L., Lopez M., and Moretta A. Identification of PVR (CD155) and Nectin-2 (CD112) as cell surface ligands for the human DNAM-1 (CD226) activating molecole. J. Exp. Med. 198 (2003) 557-567
28. Berezney R., and Coffey D.S. Nuclear Matrix. Isolation and characterization of a framework structure from rat liver nuclei. J. Cell Biol. 73 (1977) 616-637
29. Sjakste N., Sjakste T., and Vikmanis U. Role of the nuclear matrix proteins in malignant transformation and cancer diagnosis. Exp. Oncol. 26 (2004) 170-178
30. Ikeda Y., Nakamura K., Iwakami N., Hibino Y., and Sugano N. Base sequences of highly repetitive components in nuclear DNAs from rat liver and rat-ascites hepatoma. Cancer Lett. 55 (1990) 201-208
31. Nickerson J.A. Experimental observations of a nuclear matrix. J. Cell Sci. 114 (2001) 463-474
32. Ludérus M.E., den Blaauwen J.L., de Smit O.J.B., Compton D.A., and van Driel R. Binding of matrix attachment regions to lamin polymers involves single-stranded regions and the minor groove. Mol. Cell. Biol. 14 (1994) 6297-6305
33. Berezney R., and Coffey D.S. Identification of a nuclear protein matrix. Biochem. Biophys. Res. Commun. 60 (1974) 1410-1417
34. Davido T., and Getzenberg R.H. Nuclear matrix proteins as a cancer markers. J. Cell. Biochem. Suppl. 35 (2000) 136-141
35. Abad P.C., Lewis J., Mian I.S., Knowles D.W., Sturgis J., Badve S., Xie J., and Lelièvre S.A. NuMA influences higher order chromatin organization in human mammary epithelium. Mol. Biol. Cell 18 (2007) 348-361
36. Bosman F.T. The nuclear matrix in pathology. Virchows Arch. 435 (1999) 391-399
37. Coradeghini R., Barboro P., Rubagotti A., Boccardo F., Parodi S., Carmignani G., D'Arrigo C., Patrone E., and Balbi C. Differential expression of nuclear lamins in normal and cancerous prostate tissues. Oncol. Rep. 15 (2006) 609-613
38. Carpenter B., MacKay C., Alnabulsi A., MacKay M., Telfer C., Melvin W.T., and Murray G.I. The roles of heterogeneous nuclear ribonucleoproteins in tumour development and progression. Biochim. Biophys. Acta 1765 (2006) 85-100
39. Enukashvily N., Donev R., Sheer D., and Podgornaya O. Satellite DNA binding and cellular localisation of RNA helicase P68. J. Cell Sci. 118 (2005) 611-622
40. Chu P.G., and Weiss L.M. Keratin expression in human tissues and neoplasms. Histopathology 40 (2002) 403-439
41. Zatloukal K., Stumptner C., Fuchsbichler A., Fickert P., Lackner C., Trauner M., and Denk H. The keratin cytoskeleton in liver diseases. J. Pathol. 204 (2004) 367-376
42. Ding S.J., Li Y., Tan Y.X., Jiang M.R., Tian B., Liu Y.K., Shao X.X., Ye S.L., Wu J.R., Zeng R., Wang H.Y., Tang Z.Y., and Xia Q.C. From proteomic analysis to clinical significance: overexpression of cytokeratin 19 correlates with hepatocellular carcinoma metastasis. Mol. Cell. Proteomics 3 (2004) 73-81
43. Lim S.O., Park S.G., Yoo J.H., Park Y.M., Kim H.J., Jang K.T., Cho J.W., Yoo B.C., Jung G.H., and Park C.K. Expression of heat shock proteins (HSP27, HSP60, HSP70, HSP90, GRP78, GRP94) in hepatitis B virus-related hepatocellular carcinomas and dysplastic nodules. World J. Gastroenterol. 11 (2005) 2072-2079
44. Sun W., Xing B., Sun Y., Du X., Lu M., Hao C., Lu Z., Mi W., Wu S., Wei H., Gao X., Zhu Y., Jiang Y., Qian X., and He F. Proteome analysis of hepatocellular carcinoma by two-dimensional difference gel electrophoresis: novel protein markers in hepatocellular carcinoma tissues. Mol. Cell. Proteomics 6 (2007) 1798-1808
45. Chuma M., Sakamoto M., Yamazaki K., Ohta T., Ohki M., Asaka M., and Hirohashi S. Expression profiling in multistage hepatocarcinogenesis: identification of HSP70 as a molecular marker of early hepatocellular carcinoma. Hepatology 37 (2003) 198-207
46. Galande S. Chromatin (dis)organization and cancer: BUR-binding proteins as biomarkers for cancer. Curr. Cancer Drug Targets 2 (2002) 157-190
47. Käs E., Izaurralde E., and Laemmli U.K. Specific inhibition of DNA binding to nuclear scaffolds and histone H1 by distamycin. The role of oligo (dA), oligo (dT) tracts. J. Mol. Biol. 210 (1989) 587-599
48. Käs E., Poljack L., Adachi Y., and Laemmli U.K. A model for chromatin opening: stimulation of topoisomerase II and restriction enzyme cleavage of chromatin by distamycin. EMBO J. 12 (1993) 115-126
49. Reyes J.C., Muchardt C., and Yaniv M. Components of the human SWI/SNF complex are enriched in active chromatin and are associated with the nuclear matrix. J. Cell Biol. 137 (1997) 263-274
50. Balbi C., Sanna P., Barboro P., Alberti I., Barbesino M., and Patrone E. Chromatin condensation is confined to the loop and involves an all-or-none structural change. Biophys. J. 77 (1999) 2725-2735
51. van Driel R., Fransz P.F., and Verschure P.J. The eukaryotic genome: a system regulated at different hierarchical levels. J. Cell Sci. 116 (2003) 4067-4075
52. Galande S., and Kohwi-Shigematsu T. Linking chromatin architecture to cellular phenotype: BUR-binding proteins in cancer. J. Cell. Biochem. Suppl. 35 (2000) 36-45
53. Han H.J., Russo J., Kohwi Y., and Kohwi-Shigematsu T. SATB1 reprogrammes gene expression to promote breast tumour growth and metastasis. Nature 452 (2008) 187-193